These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 6390509
1. Preliminary results of adjuvant half-body irradiation in metastasising cancer of the breast. Standke E, Kunze ML, Oelssner W, Pfeiffer J. Radiobiol Radiother (Berl); 1984; 25(4):525-30. PubMed ID: 6390509 [No Abstract] [Full Text] [Related]
2. Single exposure of high-dose half-body irradiation in cases of carcinoma of the breast. Schorcht J, Herrmann T, Friedrich S, Jochem I, Winkler C. Radiobiol Radiother (Berl); 1984; 25(4):531-5. PubMed ID: 6390510 [No Abstract] [Full Text] [Related]
4. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA. Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091 [Abstract] [Full Text] [Related]
5. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Sautter-Bihl ML, Souchon R, Budach W, Sedlmayer F, Feyer P, Harms W, Haase W, Dunst J, Wenz F, Sauer R. Strahlenther Onkol; 2008 Jul 01; 184(7):347-53. PubMed ID: 19016032 [Abstract] [Full Text] [Related]
8. [Irradiation of lymph nodes areas in breast cancer]. Hennequin C, Romestaing P, Maylin C. Cancer Radiother; 2008 Nov 01; 12(6-7):559-64. PubMed ID: 18951822 [Abstract] [Full Text] [Related]
9. [Breast cancer: the majority of women need adjuvant therapy. Even in the absence of lymphatic metastases adjuvant therapy can be useful]. Schalhorn B. Fortschr Med; 1999 Apr 30; 117(12):35. PubMed ID: 10361370 [No Abstract] [Full Text] [Related]
14. Treatment of breast cancer. Zurrida S, Veronesi U. Ann Chir Gynaecol; 2000 Feb 30; 89(3):187-90. PubMed ID: 11079786 [No Abstract] [Full Text] [Related]
15. [Adjuvant therapy in breast cancer (high risk). Randomized study: radiotherapy versus combination radiotherapy and chemotherapy]. Bendel V, Emminger A, Renner K. Strahlentherapie; 1984 Jan 30; 160(1):31-4. PubMed ID: 6701925 [Abstract] [Full Text] [Related]
17. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies]. Fodor J, Polgár C, Németh G. Orv Hetil; 2000 Jul 09; 141(28):1551-5. PubMed ID: 10957865 [Abstract] [Full Text] [Related]
18. Behaviour of cell-mediated and humoral immunity in patients with metastasizing mammary carcinoma after adjuvant radiotherapy. Brock A, Standke E, Sauer H. Radiobiol Radiother (Berl); 1984 Jul 09; 25(4):537-46. PubMed ID: 6390511 [No Abstract] [Full Text] [Related]
19. Inflammatory breast cancer. Glass JL, Frazee RC. Am Surg; 1995 Feb 09; 61(2):121-4. PubMed ID: 7856970 [Abstract] [Full Text] [Related]
20. [Therapeutic results in progressive breast cancer]. Tsuda H, Momma R. Iryo; 1969 Jan 09; 23(1):26-30. PubMed ID: 5783214 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]